How to standardize the use of self-controlled analgesic pumps venously pumped into morphine for the treatment of refractory carcinoma pain

ObjectiveTo observe the clinical effect of intravenous pumping morphine using patient-controlled analgesic pumps to treat refractory carcinoma pain. Methods: A total of 32 patients with refractory cancer pain were screened and treated with PCA pump vein pump into morphine injection for analgesia. Retrospectively analyze the clinical characteristics of patients in the above cases, observe the analgesic process, and evaluate the analgesic efficacy and safety of the PCA pump. Results: The demand for morphine increased in most patients with refractory cancer pain, and the use of PCA pump vein pumping morphine could be used to quickly and effectively analgesic, and the patient's pain level was significantly reduced, the quality of life was significantly improved, and no serious adverse reactions occurred. Conclusion: The use of PCA pump to treat refractory cancer pain, reasonable control of morphine dosage, simple operation, improve patient compliance with medication, can be quick, timely and effective analgesia.